rajpharma.com Report : Visit Site

Technical data of the rajpharma.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host rajpharma.com. Currently, hosted in United States and its service provider is CloudFlare Inc. .

cirsci.org 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called cloudflare containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

'); document.write(''); function oas_ad(pos, sector) { if (oas_version = 11 && typeof (oas_rich) != 'undefined') oas_rich(pos); else oas_normal(pos, sector, ''); } function oas_ad_search(pos, sector, keyword) { var sectorname = getcorrespondingsectr(sector); if (oas_version = 11 && typeof (oas_rich) != 'undefined') { oas_rich(pos); } else { oas_normal(pos, sectorname, keyword); } } we use cookies to improve your website experience. to learn about our use of cookies and how you can manage your cookie settings, please see our cookie policy . by continuing to use the website, you consent to our use of cookies. pink sheet is part of the business intelligence division of informa plc informa plc about us investor relations talent this site is operated by a business or businesses owned by informa plc and all copyright resides with them. informa plc’s registered office is 5 howick place, london sw1p 1wg. registered in england and wales. number 8860726. informa toggle menu menu my view other publications: scrip | medtech insight | in vivo | rose sheet start trial register sign in this copy is for your personal, non-commercial use. for high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183 printed by usernamepublicrestriction already registered? sign in to continue reading. sign in thanks, we've sent a link to reset your password forgot your password? enter the email address associated with your account and an email will be sent to you to reset your password. please enter a valid email address. unfortunately we've not been able to process this request. submit need help? email: [email protected] phone: (us toll-free): +1 888-670-8900; (us collect): +1 908-547-2200 phone (uk & europe): +44 (20) 337 73737 phone (apac): +61 2 8705 6907 new to pink sheet? start a free trial today! free trial register for our free email digests: register toggle menu menu start a trial home latest news & analysis my view edit add your favourite topics for quick access policy & regulation review pathways drug safety legislation legal & ip product reviews & approvals fda advisory committees drug approvals fda performance tracker market access & reimbursement manufacturing consumer drugs clinical / r&d commercial regional coverage hot topics pricing debate meet the team ask the analyst pdf library rss feeds subscribe advertising usernamepublicrestriction already registered? sign in to continue reading. sign in thanks, we've sent a link to reset your password forgot your password? enter the email address associated with your account and an email will be sent to you to reset your password. please enter a valid email address. unfortunately we've not been able to process this request. submit need help? email: [email protected] phone: (us toll-free): +1 888-670-8900; (us collect): +1 908-547-2200 phone (uk & europe): +44 (20) 337 73737 phone (apac): +61 2 8705 6907 new to pink sheet? start a free trial today! free trial register for our free email digests: register for the latest perspectives on drug pricing, see our pricing debate hot topic. featured stories bookmark 17 jul 2018 news uk regulator considers jail for non-compliance with coming eu safety features by neena brizmohun the medicines and healthcare products regulatory agency has issued for consultation proposals on how it will ensure the uk meets its obligations to transpose the safety feature provisions of the eu falsified medicines directive. drug safety distribution united kingdom bookmark 17 jul 2018 news lilly ceo breaks from phrma, innovators with support for creates act by michael cipriano legislation that would prevent rems from blocking generics appears to be gaining momentum. generic drugs pricing debate legislation bookmark 17 jul 2018 analysis us fda generic drug office director uhl announces retirement by derrick gingery uhl, who shepherded ogd into the user fee era, will retire in february. fda generic drugs regulation bookmark 17 jul 2018 analysis biologics transition plan from us fda will consider therapeutic equivalence ratings by sue sutter while industry awaits formal guidance ahead of march 2020 transition deadline for certain protein products, fda's christl says plan will take into account therapeutic equivalence ratings when deciding whether products are 'deemed' licensed as full biologic applications or biosimilars. biosimilars biologics regulation latest news cancer, orphan, pediatric drug developers join china foreign data acceptance party 3 hours ago phrma drug pricing comments mainly stick to script 4 hours ago us fda generic drug office director uhl announces retirement 5 hours ago innovation in otc switches takes multimedia approach in us fda draft guidance 8 hours ago lilly ceo breaks from phrma, innovators with support for creates act 8 hours ago biologics transition plan from us fda will consider therapeutic equivalence ratings 9 hours ago more latest news advertisement us fda performance tracker keeping track: tpoxx wins green light for smallpox, submissions galore, and a broader approval for xtandi novel cder approvals cber novel approvals pending biosimilars advisory committees complete response letters qidp designations user fee goal dates breakthrough therapy designations european performance tracker new filings at the ema new eu approvals european chmp opinions and maa updates bookmark 04 jul 2018 news global pharma guidance tracker – june 2018 by vibha sharma stay up to date on regulatory guidelines from around the world, with the pink sheet's guidance tracker. new zealand singapore denmark clinical and research excellence awards 2018 ebook the clinical and research excellence (care) awards provides an opportunity for the pharma industry to celebrate all its achievements, and pay tribute to the people and teams behind these feats. 2017 was a successful year for the industry, which was evident by the volume and quality of the entries received for this year’s care awards. read the ebook and discover more generics in the us 2018 read this ebook and learn more about the west acceltra elastomer components program that was designed to help in this effort. learn how the acceltra component program has been helping generic biopharmaceutical manufacturers by providing a number of key features, for those high-volume products and where manufacturers would like to deal mostly with one high-performing elastomer component. read the ebook and discover more get our free email newsletter sign up to receive daily alerts from pink sheet sign up get our free email newsletter newsletter.needsregistrationmessage newsletter.needsregistrationbuttontext get our free email newsletter this email address is already in our system. please click on the button below to sign into your account and update your email preferences. manage preferences policy & regulation explore this topic set alert for policy & regulation cancel remove alert are you sure you'd like to remove this alert? you will no longer receive email updates about this topic. yes, i'm sure bookmark 17 jul 2018 news innovation in otc switches takes multimedia approach in us fda draft guidance by malcolm spicer sponsors can point consumers to video displays, website information and mobile apps to help them choose products that have been switched from rx to otc. draft guidance on innovative switch applications to be followed by rule-making in near future. consumer prescription to otc switch fda latest from regulation bookmark 17 jul 2018 analysis cancer, orphan, pediatric drug developers join china foreign data acceptance party by brian yang china officially issues regulation accepting clinical data obtained from overseas studies, with a priority on treatments for critical, rare and pediatric conditions. china regulation bookmark 17 jul 2018 analysis phrma drug pricing comments mainly stick to script by cathy kelly with only o

URL analysis for rajpharma.com

https://pink.pharmaintelligence.informa.com/ps123437/breakthrough
priority
review
designations
could
set
highwater
marks
in
2018
https://pink.pharmaintelligence.informa.com/ps123454/trump
tries
to
shame
a
defiant
pfizer
on
drug
pricing
https://pink.pharmaintelligence.informa.com/search#?subjects=prescription+to+otc+switch
https://pink.pharmaintelligence.informa.com/product-reviews-and-approvals/fda-performance-tracker
https://pink.pharmaintelligence.informa.com/ps123466/illegal
emissions
force
sanofi
production
stoppage
https://pink.pharmaintelligence.informa.com/ps123458/european
otc
shifts
bms
eyes
selling
french
business
private
equity
controls
italys
recordati
https://pink.pharmaintelligence.informa.com/search#?subjects=business+strategies
https://pink.pharmaintelligence.informa.com/policy-and-regulation/legal-and-ip
https://pink.pharmaintelligence.informa.com/search#?subjects=pharmacy+benefit+management
https://pink.pharmaintelligence.informa.com/search#?regions=united+kingdom
https://pink.pharmaintelligence.informa.com/search#?subjects=clinical+trials
https://pink.pharmaintelligence.informa.com/search#?subjects=legislation
https://pink.pharmaintelligence.informa.com/authors/eleanor-malone
https://pink.pharmaintelligence.informa.com/ps123480/french
industry
welcomes
moves
to
speed
up
access
to
innovative
drugs
https://pink.pharmaintelligence.informa.com/ps123513/lilly
ceo
breaks
from
phrma
innovators
with
support
for
creates
act

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: RAJPHARMA.COM
Registry Domain ID: 98538457_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.safenames.net
Registrar URL: http://www.safenames.net
Updated Date: 2018-05-30T07:58:41Z
Creation Date: 2003-05-30T00:31:50Z
Registry Expiry Date: 2019-05-30T00:31:50Z
Registrar: SafeNames Ltd
Registrar IANA ID: 447
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +44.1908200022
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: ART.NS.CLOUDFLARE.COM
Name Server: EMMA.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-07-18T07:17:48Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR SafeNames Ltd

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =rajpharma.com

  PORT 43

  TYPE domain

DOMAIN

  NAME rajpharma.com

  CHANGED 2018-05-30

  CREATED 2003-05-30

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited

NSERVER

  ART.NS.CLOUDFLARE.COM 173.245.59.102

  EMMA.NS.CLOUDFLARE.COM 173.245.58.112

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .